News & Updates
Filter by Specialty:
Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients
Prophylactic interferon-alpha (IFN-α) administered intranasally slashed the incidence of COVID-19 by almost half in a cohort of cancer patients in the C-SMART study.
Prophylactic intranasal IFN-α cuts COVID-19 incidence in cancer patients
20 May 2024
Which factors contribute to masked hypertension in CKD patients?
Ambulatory 24-h blood pressure (BP) monitoring (ABPM) is recommended in the presence of chronic kidney disease (CKD), given that many patients with controlled office BP have masked hypertension, suggests a recent study.
Which factors contribute to masked hypertension in CKD patients?
19 May 2024
Prednisone better than anakinra-zinc combo for severe alcohol-associated hepatitis
Use of prednisone in patients with severe alcohol-associated hepatitis (SAH) results in significantly better overall and transplant-free survival at 90 days and a lower incidence of acute kidney injury (AKI) when compared with the use of anakinra plus zinc, results of a study have shown.
Prednisone better than anakinra-zinc combo for severe alcohol-associated hepatitis
18 May 2024
Magnetic seizure therapy for bipolar mania drives high response, preserves language function
Individuals with bipolar mania appear to respond well to magnetic seizure therapy (MST) while sustaining fewer effects on language function, with the response rate not significantly different from that seen with electroconvulsive therapy (ECT), as shown in a pilot study.
Magnetic seizure therapy for bipolar mania drives high response, preserves language function
17 May 2024
HCV cure possible in people who inject drugs despite poor treatment adherence
People who inject drugs (PWID) with low adherence to sofosbuvir/velpatasvir can still be cured of hepatitis C virus (HCV) infection, suggests a study.